Sodium Phenylbutyrate

CAS No. 1716-12-7

Sodium Phenylbutyrate ( Benzenebutanoic Acid; NSC 657802; TriButyrate )

Catalog No. M12616 CAS No. 1716-12-7

Sodium Phenylbutyrate is a transcriptional regulators that act by altering chromatin structure via the modulation of HDAC activity.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 34 In Stock
100MG 49 In Stock
200MG 78 In Stock
500MG 130 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sodium Phenylbutyrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium Phenylbutyrate is a transcriptional regulators that act by altering chromatin structure via the modulation of HDAC activity.
  • Description
    Sodium Phenylbutyrate is a transcriptional regulators that act by altering chromatin structure via the modulation of HDAC activity.
  • Synonyms
    Benzenebutanoic Acid; NSC 657802; TriButyrate
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1716-12-7
  • Formula Weight
    186.18
  • Molecular Formula
    C10H11NaO2
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 30 mg/mL (161.13 mM); DMSO: 8 mg/mL (42.96 mM)
  • SMILES
    O=C([O-])CCCC1=CC=CC=C1.[Na+]
  • Chemical Name
    sodium 4-phenylbutanoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Burrage LC, et al. Mol Genet Metab. 2014 Sep-Oct;113(1-2):131-5.
molnova catalog
related products
  • WT-161

    A potent, selective, and bioavailable HDAC6 inhibitor with IC50 0.4 nM.

  • Tucidinostat

    Tucidinostat (Chidamide, HBI-8000, CS055) is a novel histone deacetylase (HDAC) inhibitor.

  • Belinostat

    Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.